Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM90A21P (Family with Sequence Similarity 90 Member A21, Pseudogene) is a non-protein-coding genomic locus belonging to the FAM90A gene family, which is primate-specific and characterized by multiple copies due to segmental duplications on chromosome 8p23.1. It is officially classified as a pseudogene and does not produce a functional protein product. Although some pseudogenes play non-coding regulatory roles (such as acting as microRNA decoys and influencing gene expression), there is no current evidence or annotation suggesting any specific biological or pathological function for FAM90A21P. This locus is not considered a receptor, enzyme, transporter, or other therapeutic target, and no drugs, biomarkers, or disease associations have been described for it. The FAM90A family's only characterized feature is a CCHC zinc-finger domain motif, found in some related members, which may be involved in nucleic acid binding, but the functional significance remains uncertain for FAM90A21P specifically.
None applicable; FAM90A21P is not an established target for therapeutic agents
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A21, pseudogene (FAM90A21P).